The overall binding free energy of the complex reached − 33.01 ± 0.08 kcal/mol, indicating that MAPK3 might be a potential target during the treatment of AP by Glycyrrhizin. This evidence concerns the gene MAPK3 and alkaline phosphatase measurement.